Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.

Authors: Authors: Tarantino P, Gupta H, Hughes ME, Files J, Strauss S, Kirkner G, Feeney AM, Li Y, Garrido-Castro AC, Barroso-Sousa R, Bychkovsky BL, DiLascio S, Sholl L, MacConaill L, Lindeman N, Johnson BE, Meyerson M, Jeselsohn R, Qiu X, Li R, Long H, Winer EP, Dillon D, Curigliano G, Cherniack AD, Tolaney SM, Lin NU.
Nat Commun 2023-11-18
View full abstract on Pubmed

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.

Authors: Authors: Singh H, Keller RB, Kapner KS, Dilly J, Raghavan S, Yuan C, Cohen EF, Tolstorukov M, Andrews E, Brais LK, da Silva A, Perez K, Rubinson DA, Surana R, Giannakis M, Ng K, Clancy TE, Yurgelun MB, Schlechter BL, Clark JW, Shapiro GI, Rosenthal MH, Hornick JL, Nardi V, Li YY, Gupta H, Cherniack AD, Meyerson M, Cleary JM, Nowak JA, Wolpin BM, Aguirre AJ.
Clin Cancer Res 2023-11-14
View full abstract on Pubmed

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.

Authors: Authors: Alessi JV, Wang X, Elkrief A, Ricciuti B, Li YY, Gupta H, Spurr LF, Rizvi H, Luo J, Pecci F, Lamberti G, Recondo G, Venkatraman D, Di Federico A, Gandhi MM, Vaz VR, Nishino M, Sholl LM, Cherniack AD, Ladanyi M, Price A, Richards AL, Donoghue M, Lindsay J, Sharma B, Turner MM, Pfaff KL, Felt KD, Rodig SJ, Lin X, Meyerson ML, Johnson BE, Christiani DC, Schoenfeld AJ, Awad MM.
J Thorac Oncol 2023-11-01
View full abstract on Pubmed

Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer.

Authors: Authors: Mäkinen N, Meyerson M.
J Clin Invest 2023-11-01
View full abstract on Pubmed

Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.

Authors: Authors: Groves A, Ward A, Li YY, Lazo de la Vega L, Nag A, Forrest SJ, Gupta HV, Thorner AR, Meyerson M, Kamihara J, Cherniack AD, Janeway KA.
Pediatr Blood Cancer 2023-11-01
View full abstract on Pubmed

Dosage amplification dictates oncogenic regulation by the NKX2-1 lineage factor in lung adenocarcinoma.

Authors: Authors: Pulice JL, Meyerson M.
bioRxiv 2023-10-27
View full abstract on Pubmed

XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells.

Authors: Authors: Zou T, Zhou M, Gupta A, Zhuang P, Fishbein AR, Wei HY, Zhang Z, Cherniack AD, Meyerson M.
bioRxiv 2023-08-03
View full abstract on Pubmed

Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation.

Authors: Authors: Gibson WJ, Sadagopan A, Shoba VM, Choudhary A, Meyerson M, Schreiber SL.
bioRxiv 2023-07-07
View full abstract on Pubmed

Cancer aneuploidies are shaped primarily by effects on tumour fitness.

Authors: Authors: Shih J, Sarmashghi S, Zhakula-Kostadinova N, Zhang S, Georgis Y, Hoyt SH, Cuoco MS, Gao GF, Spurr LF, Berger AC, Ha G, Rendo V, Shen H, Meyerson M, Cherniack AD, Taylor AM, Beroukhim R.
Nature 2023-07-01
View full abstract on Pubmed

Molecular portraits of lung cancer evolution.

Authors: Authors: Hayes TK, Meyerson M.
Nature 2023-04-01
View full abstract on Pubmed